Intestinal Flora Metabolite Trimethylamine Oxide Is Inextricably Linked to Coronary Heart Disease
Authors:
Open Access
- 19 November 2022
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 81 (3) , 175-182
Abstract
Atherosclerotic coronary heart disease is a common cardiovascular disease with high morbidity and mortality. In recent years, the incidence of coronary heart disease has gradually become younger, and biomarkers for predicting coronary heart disease have demonstrated valuable clinical prospects. Several studies have established an association between coronary heart disease and intestinal flora metabolites, including trimethylamine oxide (TMAO), which has attracted widespread attention from researchers. Investigations have also shown that plasma levels of TMAO and its precursors can predict cardiovascular risk in humans; however, TMAO’s mechanism of action in causing coronary heart disease is not fully understood. This review examines TMAO’s generation, the mechanism through which it causes coronary heart disease, and the approaches used to treat TMAO-caused coronary heart disease to possible avenues for future research on coronary heart disease and find new concepts for the treatment of the condition.Keywords
This publication has 101 references indexed in Scilit:
- Insight in Genome-Wide Association of Metabolite Quantitative Traits by Exome Sequence AnalysesPLOS Genetics, 2015
- Prognostic Value of Elevated Levels of Intestinal Microbe-Generated Metabolite Trimethylamine-N-Oxide in Patients With Heart FailureJACC, 2014
- The Epidemic of the 20th Century: Coronary Heart DiseaseThe American Journal of Medicine, 2014
- An atlas of genetic influences on human blood metabolitesNature Genetics, 2014
- Genetic Determinants Influencing Human Serum Metabolome among African AmericansPLOS Genetics, 2014
- Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiotaProceedings of the National Academy of Sciences, 2014
- Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular RiskNew England Journal of Medicine, 2013
- Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosisNature Medicine, 2013
- Intestinal microbiota determine severity of myocardial infarction in ratsThe FASEB Journal, 2012
- Probiotic modulation of symbiotic gut microbial–host metabolic interactions in a humanized microbiome mouse modelMolecular Systems Biology, 2008